Reshaping human antibodies for therapy

@article{Riechmann1988ReshapingHA,
  title={Reshaping human antibodies for therapy},
  author={L. Riechmann and M. Clark and H. Waldmann and G. Winter},
  journal={Nature},
  year={1988},
  volume={332},
  pages={323-327}
}
A human IgGI antibody has been reshaped for serotherapy in humans by introducing the six hypervariable regions from the heavy- and light-chain variable domains of a rat antibody directed against human lymphocytes. The reshaped human antibody is as effective as the rat antibody in complement and is more effective in cell-mediated lysis of human lymphocytes. 
1,543 Citations

Figures, Tables, and Topics from this paper

A humanized antibody against human cytomegalovirus (CMV) gpUL75 (gH) for prophylaxis or treatment of CMV infections.
  • 19
  • Highly Influenced
  • PDF
Humanisation of monoclonal antibodies for therapy.
  • 57
  • Highly Influenced
CDR Repair: A Novel Approach to Antibody Humanization
  • 10
  • PDF
Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth.
  • 254
  • Highly Influenced
  • PDF
A humanized monovalent CD3 antibody which can activate homologous complement
  • 57
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 36 REFERENCES
Tolerance to rat monoclonal antibodies. Implications for serotherapy
  • 158
  • PDF
Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies
  • 596
  • PDF
Production of functional chimaeric mouse/human antibody
  • 524
  • PDF
Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.
  • 211
  • PDF
...
1
2
3
4
...